Providing consulting services to the medical device industry.Specialist expertise in International business and market development, commercial excellence, strategy and sales force excellence.

Focus on where to play and how to win - delivering a transformational business model change process in Europe for a $1.7BN regional unit to fundamentally evolve our go to market model and the value we bring to our customers. • Key member of the leadership team for the European region that recently posted its sixth consecutive quarter of growth, following a previous 10 quarter period of flat or declining revenues.• Major challenges included getting strategic alignment and commitment from, regional Vice Presidents, business and functional leads and balancing evolving customer needs with cost control.• A fully matrixed staff role, so high skills levels required in influence, passion and commitment, prioritisation and focus to balance sustainable success and quick wins.

Reporting to the Global President of the Urology Women’s Health division, delivering turnaround financial performance in the EMEA region. Concurrently responsible for management of the Latin American business unit and strategic support to all international regions.• International revenue grew from $94MM in 2008 to $140MM in 2012.• International delivered 12% growth in 2012, outperforming the market and plan for the year.• EMEA delivered 6% growth vs market growth of 3%, as a result of improved sales execution. Activities and investments in Latin America delivered 16% growth on a current revenue base of $10 MM USD, versus market growth of 10%.• Through full P+L accountability in the EMEA region, delivered in excess of $55 MM sales and $27 MM in Operating Income. A fully leveraged P+L grew income in line with sales.• Through matrix leadership, drove the strategic direction to deliver an additional $86MM in sales in the non- EMEA regions of the international business. • Directed and developed a strong divisional leadership team of 6 international marketing staff, 1 Sales Director for EMEA, 1 Business Unit Manager for Brazil, plus a mix of over 50 direct and 40 matrix country based sales and marketing staff.• A key member of the divisional senior leadership team, drove focus on global growth in the division through development of international strategic plan including pipeline management, new product development and launch schedule and strong influence management skills deployment.

Reporting to the Vice President Marketing International, responsible for international strategic direction of the Endoscopy and Urology and Women’s businesses to achieve combined revenues in excess of $450MM.• Delivered revenue in excess of $380 MM USD for Endoscopy and $90MM for Urology Women’s Health, from a 2006 base of $320MM for Endoscopy and $70MM for Urology.• Developed world class physician education programs to support business development and effective product launches. • Developed and presented “Incubator model” for Urology Women’s Health business in EMEA to senior corporate team, resulting in organisation model change, business transformation and return to growth.• $7MM budget and team of 12 international marketing, director of Endoscopy and 190+ matrix country based sales and marketing teams. • Developed and delivered full international strategic and execution plan.

Reporting to the President Europe, responsible for the support of all sales related activities in Europe and contributing to operating revenue of over $1.1 B in 2005. Focused on upgrading our commercial selling capabilities in the European business, with a major focus on sales leadership. Executed full international review of entire BSCI sales management population, including improving cross-divisional sales.

Reporting to the Vice President Endosurgery Europe, responsible for the sales and marketing activities of the Boston Scientific’s Urology Women’s Health businesses in the Europe. • Delivered consistent double digit sales growth for the 6 year period, driving business transformation for Urology in Europe and taking operating margin from ($2MM ) USD in 1998 to positive $8MM 2005. • Initiatives included successfully introduction of a 2nd franchise (Women’s Health) to European division to fuel accelerated growth.